Login / Signup

Efficient Prevention of Marine Biofilm Formation Employing a Surface-Grafted Repellent Marine Peptide.

Moshe HerzbergMattias BerglinSarai EliahuLovisa BodinKarin AgreniusAmir ZlotkinJohan Svenson
Published in: ACS applied bio materials (2021)
Creation of surfaces resistant to the formation of microbial biofilms via biomimicry has been heralded as a promising strategy to protect a range of different materials ranging from boat hulls to medical devices and surgical instruments. In our current study, we describe the successful transfer of a highly effective natural marine biofilm inhibitor to the 2D surface format. A series of cyclic peptides inspired by the natural equinatoxin II protein produced by Beadlet anemone ( Actinia equine ) have been evaluated for their ability to inhibit the formation of a mixed marine microbial consortium on polyamide reverse osmosis membranes. In solution, the peptides are shown to effectively inhibit settlement and biofilm formation in a nontoxic manner down to 1 nM concentrations. In addition, our study also illustrates how the peptides can be applied to disperse already established biofilms. Attachment of a hydrophobic palmitic acid tail generates a peptide suited for strong noncovalent surface interactions and allows the generation of stable noncovalent coatings. These adsorbed peptides remain attached to the surface at significant shear stress and also remain active, effectively preventing the biofilm formation over 24 h. Finally, the covalent attachment of the peptides to an acrylate surface was also evaluated and the prepared coatings display a remarkable ability to prevent surface colonization at surface loadings of 55 ng/cm 2 over 48 h. The ability to retain the nontoxic antibiofilm activity, documented in solution, in the covalent 2D-format is unprecedented, and this natural peptide motif displays high potential in several material application areas.
Keyphrases
  • biofilm formation
  • candida albicans
  • pseudomonas aeruginosa
  • staphylococcus aureus
  • escherichia coli
  • amino acid
  • cystic fibrosis
  • microbial community
  • small molecule
  • solid state
  • human health
  • patient reported outcomes